CNNFDA vaccine advisers vote to recommend booster doses of Covid-19 vaccine in people 65 and older and those at high riskSep 18, 2021Jacqueline Howard, Maggie Fox & Jamie GumbrechtBy Jacqueline Howard, Maggie Fox & Jamie Gumbrechtmore_vert
PfizerContinuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert BourlaSep 16, 2021more_vert
Reuters.comModerna says COVID-19 vaccine protection wanes, makes case for boosterSep 16, 2021Julie SteenhuysenBy Julie Steenhuysenmore_vert
NBC NewsFDA advisory group rejects Covid boosters for most, limits to high-risk groupsSep 17, 2021more_vert
PBS NewsHourFDA advisory panel rejects widespread Pfizer vaccine booster shotsSep 17, 2021Lauran Neergaard & Matthew PerroneBy Lauran Neergaard & Matthew Perronemore_vert
BBC.comCovid-19: How effective is a third vaccine dose?Sep 16, 2021Zaria GorvettBy Zaria Gorvettmore_vert
The New York TimesNew Study of Covid Booster Shots Fans Debate Over Benefits (Published 2021)Aug 7, 2023Apoorva MandavilliBy Apoorva Mandavillimore_vert
Financial TimesFDA panel votes against Pfizer's Covid-19 booster jab applicationSep 17, 2021Jamie Smyth, Nikou Asgari & Kiran StaceyBy Jamie Smyth, Nikou Asgari & Kiran Staceymore_vert
The Guardian USFDA advisers vote not to recommend Pfizer booster shots for most AmericansSep 17, 2021Jessica GlenzaBy Jessica Glenzamore_vert
CNNModerna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC-led study saysSep 17, 2021Maggie FoxBy Maggie Foxmore_vert
CNBCFDA panel recommends Pfizer's Covid booster doses for people 65 and older after rejecting third shots for general populationSep 17, 2021Berkeley Lovelace, Robert Towey & Berkeley Lovelace Jr.By Berkeley Lovelace, Robert Towey & Berkeley Lovelace Jr.more_vert